May 20, 2026
1 min read

Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M

Gilead has broadened its partnership with Korean manufacturer Yuhan, agreeing to a $140 million supply deal for active pharmaceutical ingredients for an undisclosed product.

Leave a Reply

Your email address will not be published.

Previous Story

Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference MedNews

Next Story

Sirio unveils nutritional gummies compliant with Australian regulations

Previous Story

Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference MedNews

Next Story

Sirio unveils nutritional gummies compliant with Australian regulations

Latest from Blog

Go toTop